Page last updated: 2024-09-03

4-benzyl-3-crotonyl-2-oxazolidinone and Acute Liver Injury, Drug-Induced

4-benzyl-3-crotonyl-2-oxazolidinone has been researched along with Acute Liver Injury, Drug-Induced in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bai, F; Huang, Q; Lin, X; Lu, C; Lu, S; Nie, J; Zhu, X; Zhuo, L1

Other Studies

1 other study(ies) available for 4-benzyl-3-crotonyl-2-oxazolidinone and Acute Liver Injury, Drug-Induced

ArticleYear
Didymin ameliorates hepatic injury through inhibition of MAPK and NF-κB pathways by up-regulating RKIP expression.
    International immunopharmacology, 2017, Volume: 42

    Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2E1; Cytokines; Flavonoids; Glycosides; Humans; Inflammation Mediators; Lipid Peroxidation; Male; Mice; Mice, Inbred ICR; Origanum; Oxazolidinones; Phosphatidylethanolamine Binding Protein; RAW 264.7 Cells; Reactive Oxygen Species

2017